GKIM
BMY icon

GW&K Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

GW&K Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82K Sell
1,420
-34
-2% -$1.95K ﹤0.01% 504
2026
Q1 		$88K Buy
1,454
+30
+2% +$1.75K ﹤0.01% 474
2025
Q4 		$77K Buy
1,424
+205
+17% +$9.86K ﹤0.01% 482
2025
Q3 		$55K Sell
1,219
-463
-28% -$21.6K ﹤0.01% 516
2025
Q2 		$78K Buy
1,682
+514
+44% +$25.2K ﹤0.01% 448
2025
Q1 		$71K Sell
1,168
-10
-0.8% -$583 ﹤0.01% 437
2024
Q4 		$67K Buy
1,178
+111
+10% +$6.2K ﹤0.01% 432
2024
Q3 		$55K Buy
1,067
+344
+48% +$16.1K ﹤0.01% 454
2024
Q2 		$30K Sell
723
-181
-20% -$8.1K ﹤0.01% 496
2024
Q1 		$49K Buy
904
+221
+32% +$11.3K ﹤0.01% 430
2023
Q4 		$35K Sell
683
-37
-5% -$1.94K ﹤0.01% 439
2023
Q3 		$42K Buy
720
+54
+8% +$3.31K ﹤0.01% 406
2023
Q2 		$43K Buy
+666
New +$44.7K ﹤0.01% 393
2022
Q3 		– Sell
-265
Closed -$20K – 453
2022
Q2 		$20K Buy
265
+109
+70% +$8.3K ﹤0.01% 415
2022
Q1 		$11K Buy
+156
New +$10.5K ﹤0.01% 427
2015
Q1 		– Sell
-176,054
Closed -$10.4M – 222
2014
Q4 		$10.4M Buy
176,054
+2,842
+2% +$160K 0.25% 131
2014
Q3 		$8.87M Buy
173,212
+5,811
+3% +$290K 0.23% 130
2014
Q2 		$8.12M Sell
167,401
-468
-0.3% -$23.1K 0.21% 137
2014
Q1 		$8.72M Sell
167,869
-117,097
-41% -$6.23M 0.23% 133
2013
Q4 		$15.1M Sell
284,966
-93,118
-25% -$4.74M 0.41% 96
2013
Q3 		$17.5M Buy
378,084
+20,248
+6% +$889K 0.53% 79
2013
Q2 		$16M Buy
+357,836
New +$15.5M 0.59% 79

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GW&K Investment Management's BMY Position: Q2 2026 in Review

GW&K Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 2.3% in Q2 2026, selling an estimated $1.95K and leaving 1,420 shares worth $82K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

GW&K Investment Management first reported a position in BMY in Q2 2013 and has held it in 22 quarters since. The position peaked at $17.5M in Q3 2013. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • GW&K Investment Management held 1,420 shares of Bristol-Myers Squibb worth $82K as of Q2 2026.
  • GW&K Investment Management sold 34 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.95K.
  • Bristol-Myers Squibb made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #504 holding.
  • GW&K Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 22 quarters since.
  • GW&K Investment Management's Bristol-Myers Squibb position peaked at $17.5M in Q3 2013.
  • 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.